Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters











Publication year range
4.
Indian J Cancer ; 51(4): 477-80, 2014.
Article in English | MEDLINE | ID: mdl-26842169

ABSTRACT

BACKGROUND: Hospitalization for fever in cancer patients is associated with considerable morbidity, mortality, and cost. AIM: The aim of this study was to study the bacterial spectrum and susceptibility patterns of pathogens in culture positive patients from the oncology unit of our hospital. METHODS: We retrospectively reviewed the medical records of patients admitted in our cancer center (medical, radiation, and surgical oncology) from January to December 2013. Blood and respiratory secretions from the indoor patients were evaluated. RESULTS: Of the total 693 samples, 76.4% were Gram-negative and 23.6% were Gram-positive. The most common bacterial isolates among Gram-negative organisms in blood were Escherichia coli, Salmonella and among the Gram-positive organism were Staphylococcus aureus and Enterococcus. Among the blood isolates extended spectrum of beta-lactamase, multidrug-resistant (carbapenem-resistant) and pan resistant bugs were seen in 47%, 15%, and 5% of the blood isolates. Among the Gram-positive organisms, 25% respiratory isolates were vancomycin-resistant Enterococci. CONCLUSION: We observed a high incidence of Gram-negative isolates with clinically significant resistance to first-line antibiotics such as cephalosporin's, piperacillin tazobactum, and fluoroquinolones.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacterial Infections/microbiology , Drug Resistance, Bacterial , Gram-Negative Aerobic Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Neoplasms/complications , Bacterial Infections/drug therapy , Cancer Care Facilities , Gram-Negative Aerobic Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Humans , India , Microbial Sensitivity Tests , Retrospective Studies , Tertiary Care Centers
5.
Curr Med Chem ; 18(11): 1723-31, 2011.
Article in English | MEDLINE | ID: mdl-21428879

ABSTRACT

Tuberculosis is a major global health challenge and is far from being controlled. Development of resistance to currently available drugs due to the successful adaptation of the pathogen has been a major contributing factor for its control failure. Presently, there is an immense interest in identification of pathways, unique to the intracellular environment that could be utilized for the development of new and better drugs. In this sequence, targeting essential functions of Mycobacterium tuberculosis has emerged as a reliable strategy for containing the spread of the disease by this organism. The fact that iron has been known to be the key player required for its survival and ability to spread infection, the organism must carefully balance iron acquisition with iron uptake for its infectivity. Conversely, this iron homeostatic process could be disrupted to interfere with the survival and replication of this bacterium in host. Urgency to develop such an approach has been further strengthened with the worldwide recrudescence of tuberculosis especially in the developing nations of the world. In the current review, we have focused on the recent developments in targeting the essential functions of mycobacterium especially interfering in its iron homeostatic process. The relevance of iron for mycobacterial virulence, the intracellular survival and the immense potential of targeting iron-sulfur (Fe-S) cluster containing proteins in tuberculosis drug discovery has been discussed.


Subject(s)
Iron/metabolism , Molecular Targeted Therapy/methods , Mycobacterium tuberculosis/drug effects , Tuberculosis/drug therapy , Homeostasis/drug effects , Humans , Mycobacterium tuberculosis/metabolism , Mycobacterium tuberculosis/pathogenicity
6.
Bone Marrow Transplant ; 43(2): 115-9, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18794872

ABSTRACT

In developing countries, it is important to ascertain the safety of performing allogeneic hematopoietic SCT (HSCT) in single rooms without high-efficiency particulate air (HEPA) filters. We present our experience of performing 40 such transplants from July 2004 to November 2007. Source of stem cells was peripheral blood in 33, bone marrow in six and combined in one. G-CSF started from day +1. The indications were SAA-18, CML-7, AML-7, ALL-2, myelodysplastic syndrome-2 and thalassemia major-4. The median age was 19 years (range 2.2-46) with 29 male and 11 female participants. Antibacterial and antifungal prophylaxis was administered along with conditioning, and at the onset of fever, systemic antibiotics were started. Antifungal agents were added if fever persisted for 3 days. Median time for neutrophil engraftment was 10 days (range 8-17). Fever occurred in 38 (95%) for a median of 5 days (range 1-38), and blood cultures were positive in seven (17.5%). Systemic antibiotics were used in 95% and antifungals in 57.5% cases. The 30-day mortality was nil, and 100-day mortality was 1 (2.5%). After day 100, there were eight fatalities (20%) due to chronic GVHD-3, relapse-2, graft rejection-2, disseminated tuberculosis and aspergillosis-1. Our experience suggests that allogeneic HSCT can be safely performed in non-HEPA filter rooms in India.


Subject(s)
Filtration/instrumentation , Hematopoietic Stem Cell Transplantation/methods , Ventilation/methods , Adolescent , Adult , Anti-Infective Agents/therapeutic use , Child , Child, Preschool , Female , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , India , Male , Middle Aged , Opportunistic Infections/prevention & control , Patient Isolation , Postoperative Complications/prevention & control , Treatment Outcome , Young Adult
9.
Haemophilia ; 14(5): 952-5, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18637845

ABSTRACT

We investigated 52 of 457 patients with congenital factor deficiencies with 57 episodes of intracranial haemorrhage (ICH) between 1998 and 2007. There were 38 severe haemophiliacs, 6 with factor XIII deficiency, 5 with factor X deficiency, 2 factor V-deficient patients, and 1 with type 3 von Willebrand disease (VWD). The median age was 8 years (range 1 month-22 years). Most patients were below 15 years of age (86.5%). All patients with factor X deficiency were between 1 and 5 months of age. ICH was the primary bleeding episode leading to detection of factor deficiency in 19.2% (five patients with severe haemophilia and all patients with factor X deficiency). Trauma caused bleeding in 66%. None of the patients with factor X deficiency had history of prior trauma. Surgery was performed in five patients with subdural haematomas, all of whom survived. Conservative factor replacement with 100% correction for 3 days followed by 50-60% correction for 7 days was possible in 60% patients. Seizures requiring prolonged therapy were noted in eight patients. Death was recorded in 15 patients (29%). Inadequate therapy in the form of delay or insufficient replacement was noted in 7/15 deaths. ICH was seen in 11.3% of all patients with coagulation factor deficiencies. Factor X deficiency presented with ICH at an earlier age. Inadequate replacement therapy including delayed treatment caused nearly 50% of all deaths. Most patients can be managed satisfactorily with adequate replacement therapy alone, with surgery being reserved for those with worsening neurological conditions.


Subject(s)
Blood Coagulation Disorders, Inherited/complications , Intracranial Hemorrhages/etiology , Adolescent , Child , Child, Preschool , Factor V Deficiency/complications , Factor X Deficiency/complications , Hemophilia A/complications , Humans , Infant , Intracranial Hemorrhages/therapy , Male , Retrospective Studies , Young Adult
10.
Indian J Cancer ; 45(2): 41-4, 2008.
Article in English | MEDLINE | ID: mdl-18626146

ABSTRACT

BACKGROUND: Hairy-cell leukemia (HCL), lymphoproliferative disease of older age, is characterized by projections from surface of abnormal cells. AIM: The aim was to study the clinical presentation and ultrastructural changes in hairy cells (HCs) following cladribine treatment. SETTINGS AND DESIGN: Clinical presentation, peripheral smear, bone marrow aspiration and biopsy of HCL cases diagnosed over a period of three years were reviewed. MATERIALS AND METHODS: Consecutive HCL cases in Hematology clinic of a tertiary care center were enrolled. Tartarate-resistant acid phosphatase (TRAP) test was done to detect HCs and electron microscopy was done to demonstrate initial ultrastructural changes and alterations following cladribine therapy. RESULTS: Fifteen cases of HCL, aged 32-57 years (median 47 years) were studied. The clinical presentation included splenomegaly in 15 (100%), fever in 10 (67%), hepatomegaly and pain abdomen in eight (53%), fatigue in nine (60 %) cases. The commonest laboratory features were monocytopenia in 13 (87%), neutropenia in 12 (80%), anemia in 10 (67 %) and pancytopenia in nine (60%). All patients showed symptomatic improvement on cladribine therapy. Electron microscopy after treatment (three months) showed loss of the finger like projections, characteristic bald lymphocytes, loss of ribosomal lamellar complexes, as well as decrease in mitochondria and vacuoles. CONCLUSIONS: Indian patients with HCL are younger. Cladribine is an effective therapy for these patients and leads to complete response in most of the patients. There is a significant improvement in the ultrastructural features following cladribine therapy.


Subject(s)
Antineoplastic Agents/therapeutic use , Cladribine/therapeutic use , Leukemia, Hairy Cell/drug therapy , Acid Phosphatase/analysis , Adult , Female , Humans , India , Isoenzymes/analysis , Leukemia, Hairy Cell/pathology , Male , Microscopy, Electron , Middle Aged , Mitochondria/ultrastructure , Tartrate-Resistant Acid Phosphatase
11.
J Assoc Physicians India ; 54: 203-6, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16800347

ABSTRACT

Molecularly targeted therapy is a novel approach in cancer treatment. Imatinib, a specific tyrosine kinase inhibitor, since its inception in 1990s, has become the first-line drug in management of chronic myelogenous leukemia (CML) chronic phase. It has also shown promising results in treatment of gastro-intestinal stromal tumors, clonal eosinophilic disorders and Philadelphia chromosome positive acute lymphatic leukemia. The efficacy of imatinib has geared up further research into development of designer drugs with molecular targets. This review gives a comprehensive description of the development, biology, utility, dosing, and limitations of imatinib mesylate.


Subject(s)
Piperazines/pharmacology , Protein Kinase Inhibitors/pharmacology , Pyrimidines/pharmacology , Benzamides , Eosinophilia/drug therapy , Gastrointestinal Stromal Tumors/drug therapy , Humans , Imatinib Mesylate , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Philadelphia Chromosome , Piperazines/therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Protein Kinase Inhibitors/therapeutic use , Pyrimidines/therapeutic use
12.
Indian J Exp Biol ; 38(10): 1031-5, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11324156

ABSTRACT

Changes in ascorbate content and its enzymatic utilization pattern were studied in embryonic axes and cotyledons of sal seeds undergoing rapid loss of viability, at ambient conditions. Ascorbate levels were significantly higher initially in the embryonic axes (0.32 mg/g fresh weight) and cotyledons (0.21 mg/g fresh weight) of freshly mature, relatively hydrated (42.2% moisture content) and 100% viable sal seeds. It declined sharply as the tissues; embryonic axes and cotyledons, desiccated with absolutely no detectable amount in non-viable seeds (21% moisture content). Significantly strong correlation was obtained between desiccation of embryonic axes (r = 0.96) and cotyledon (r = 0.97) with loss of ascorbate levels and loss of germinability. Higher rates of ascorbic acid utilization (AAU) recorded in the embryonic axes of 100% viable seed declined sharply as the seed viability reduced due to desiccation below 36.8% moisture content. AAU was not detected in the cotyledons.


Subject(s)
Ascorbic Acid/metabolism , Rosales/metabolism , Seeds/metabolism , Rosales/embryology
13.
Liver ; 15(3): 149-52, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7674842

ABSTRACT

The present study aimed to evaluate the effect of UV-B irradiation on the functional integrity, and the metabolic and detoxifying capacity of isolated rat hepatocytes. Isolated rat hepatocytes were irradiated in various doses (400 Jm-2, 600 Jm-2, 800 Jm-2 and 1000 Jm-2). The cells were assayed for total lactate dehydrogenase, Na(+)-K(+)-ATPase, ornithine carbamyltransferase activity (OCT) and urea production capacity. Lactate dehydrogenase and Na(+)-K(+)-ATPase activity were significantly decreased in all four irradiated groups (P < 0.001), whereas viability, OCT and urea production capacity showed no alterations.


Subject(s)
Liver/radiation effects , Ultraviolet Rays , Animals , Cell Survival/radiation effects , In Vitro Techniques , L-Lactate Dehydrogenase/metabolism , Liver/cytology , Liver/metabolism , Ornithine Carbamoyltransferase/metabolism , Radiation Dosage , Rats , Rats, Wistar , Sodium-Potassium-Exchanging ATPase/metabolism , Urea/metabolism
15.
Vet Parasitol ; 25(1): 75-7, 1987 Jun.
Article in English | MEDLINE | ID: mdl-3114939

ABSTRACT

A close identity in virulence and cross-protection of four isolates of Theileria annulata was observed when infection was produced in naive, crossbred (Bos taurus male X B. indicus female) male calves. The evidence that strains of T. annulata in India differ in virulence and immunogenicity is equivocal at present.


Subject(s)
Apicomplexa/immunology , Theileriasis/parasitology , Animals , Antigens, Protozoan/immunology , Apicomplexa/pathogenicity , Cattle , Cross Reactions , India , Male , Theileriasis/immunology , Ticks , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL